Leila Alland insider trades
Open-market stock purchases and sales by Leila Alland, Director at Abeona Therapeutics Inc, from SEC Form 4 filings since Apr 7, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +14%.
Open-market stock purchases and sales by Leila Alland, Director at Abeona Therapeutics Inc, from SEC Form 4 filings since Apr 7, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +14%.